Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $100,000 |
Sells | 31 | $4,643,804 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 5,497 | 68.6531 | 377,386 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 4,800 | 69.6748 | 334,439 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 7,240 | 70.7161 | 511,985 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 1,958 | 71.4897 | 139,977 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 2,043 | 72.9538 | 149,045 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 1,510 | 73.7099 | 111,302 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 60 | 74.3389 | 4,460 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 800 | 66.6038 | 53,283 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 459 | 67.9364 | 31,183 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 3,151 | 68.9779 | 217,349 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 6,186 | 70.1507 | 433,952 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 8,580 | 70.9112 | 608,418 | D |
19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 3,131 | 71.8318 | 224,905 | D |
31 Oct 2024 17:13 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Oct 2024 | Sale | 2,154 | 66.6 | 143,456 | D |
18 Sep 2024 16:28 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 16 Sep 2024 | Sale | 10,501 | 37.59 | 394,733 | D |
11 Sep 2024 20:10 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 09 Sep 2024 | Sale | 3,639 | 33.33 | 121,288 | D |
31 Jul 2024 16:40 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Jul 2024 | Sale | 2,154 | 33.54 | 72,245 | D |
18 Jun 2024 17:17 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 17 Jun 2024 | Sale | 7,683 | 28.31 | 217,506 | D |
11 Jun 2024 16:13 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 10 Jun 2024 | Sale | 2,652 | 24.92 | 66,088 | D |
30 Apr 2024 16:30 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Apr 2024 | Sale | 6,325 | 11.0368 | 69,808 | D |
19 Mar 2024 16:15 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | CHIEF EXECUTIVE OFFICER | 18 Mar 2024 | Sale | 8,559 | 10.5925 | 90,661 | D |
13 Mar 2024 16:24 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | CHIEF EXECUTIVE OFFICER | 12 Mar 2024 | Sale | 2,618 | 9.2097 | 24,111 | D |
19 Dec 2023 21:26 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Dec 2023 | Sale | 11,734 | 2.1594 | 25,338 | D |
12 Dec 2023 16:06 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 11 Dec 2023 | Sale | 3,673 | 1.6104 | 5,915 | D |
19 Sep 2023 18:09 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Sep 2023 | Sale | 10,752 | 4.1619 | 44,749 | D |
12 Sep 2023 18:42 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 11 Sep 2023 | Sale | 2,675 | 4.624 | 12,369 | D |
21 Jun 2023 16:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 20 Jun 2023 | Sale | 311 | 6.33 | 1,969 | D |
21 Jun 2023 16:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 20 Jun 2023 | Sale | 7,654 | 6.3703 | 48,758 | D |
13 Jun 2023 17:23 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 12 Jun 2023 | Sale | 2,674 | 6.4898 | 17,354 | D |
18 May 2023 19:21 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 16 May 2023 | Sale | 8,685 | 6.4985 | 56,439 | D |
13 Mar 2023 19:26 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 10 Mar 2023 | Sale | 92,644 | 0.3598 | 33,333 | D |
28 Nov 2022 18:33 | WGS | Sema4 Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 28 Nov 2022 | Purchase | 185,185 | 0.54 | 100,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)